• Campbell DG. 1979. Pigmentary dispersion and glaucoma. A new theory. Arch Ophthalmol 97:16671672.
  • Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, et al. 1991. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337339.
  • Doyle A, Hamard P, Puech M, Lachkar Y. 2005. Asymmetric pigmentary glaucoma in a patient with marfan's syndrome. Graefes Arch Clin Exp Ophthalmol 243:955957.
  • Epstein DL, Freddo TF, Anderson PJ, Patterson MM, Bassett-Chu S. 1986. Experimental obstruction to aqueous outflow by pigment particles in living monkeys. Invest Ophthalmol Vis Sci 27:387395.
  • Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz HC, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson PN, Ades LC, Biggin A, Benetts B, Brett M, Holman KJ, De Backer J, Coucke P, Francke U, De Paepe A, Jondeau G, Boileau C. 2007. Effect of mutation type and location on clinical outcome in 1,013 probands with marfan syndrome or related phenotypes and fbn1 mutations: An international study. Am J Hum Genet 81:454466.
  • Fuchshofer R, Tamm ER. 2012. The role of tgf-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res 347:279290.
  • Gottanka J, Johnson DH, Grehn F, Lutjen-Drecoll E. 2006. Histologic findings in pigment dispersion syndrome and pigmentary glaucoma. J Glaucoma 15:142151.
  • Grant WM. 1963. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol 69:783801.
  • Hann CR, Fautsch MP. 2011. The elastin fiber system between and adjacent to collector channels in the human juxtacanalicular tissue. Invest Ophthalmol Vis Sci 52:4550.
  • Izquierdo NJ, Traboulsi EI, Enger C, Maumenee IH. 1992. Glaucoma in the marfan syndrome. Trans Am Ophthalmol Soc 90:111117; discussion 118–122.
  • Johnstone M, Martin E, Jamil A. 2011. Pulsatile flow into the aqueous veins: Manifestations in normal and glaucomatous eyes. Exp Eye Res 92:318327.
  • Karickhoff JR. 1992. Pigmentary dispersion syndrome and pigmentary glaucoma: A new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg 23:269277.
  • Kupfer C, Kuwabara T, Kaiser-Kupfer M. 1975. The histopathology of pigmentary dispersion syndrome with glaucoma. Am J Ophthalmol 80:857862.
  • Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. 2010. The revised ghent nosology for the marfan syndrome. J Med Genet 47:476485.
  • Lutjen-Drecoll E, Shimizu T, Rohrbach M, Rohen JW. 1986. Quantitative analysis of ‘plaque material’ between ciliary muscle tips in normal- and glaucomatous eyes. Exp Eye Res 42:457465.
  • Murphy CG, Johnson M, Alvarado JA. 1992. Juxtacanalicular tissue in pigmentary and primary open angle glaucoma. The hydrodynamic role of pigment and other constituents. Arch Ophthalmol 110:17791785.
  • Potash SD, Tello C, Liebmann J, Ritch R. 1994. Ultrasound biomicroscopy in pigment dispersion syndrome. Ophthalmology 101:332339.
  • Scott A, Kotecha A, Bunce C, Balidis M, Garway-Heath DF, Miller MH, Wormald R. 2011. Yag laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial. Ophthalmology 118:468473.
  • Wheatley HM, Traboulsi EI, Flowers BE, Maumenee IH, Azar D, Pyeritz RE, Whittum-Hudson JA. 1995. Immunohistochemical localization of fibrillin in human ocular tissues. Relevance to the marfan syndrome. Arch Ophthalmol 113:103109.